Drugs and biologicals
Ended Awarded
- Contract number
- HHSN26300227
- Awardee
-
Pierce Biotechnology Inc. UEI CCSJMTEVB1V7 Part of Thermo Electron Corporation
- Awarding agency
-
Office of the Director
National Institutes of Health, Department of Health and Human Services
- Obligated
- $5,692
Award facts
- Contract value 100% obligated
- $5,692.44 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325998 All Other Miscellaneous Chemical Product and Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 3 offers Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Rockford, IL 61105, USA
Award details come from SAM.gov/FPDS.
About this award
Pierce Biotechnology Inc., a subsidiary of Thermo Electron Corporation, received a federal contract award for drugs and biologicals on February 12, 2013, with an ultimate completion date of February 28, 2013. This Blanket Purchase Agreement (BPA) call, issued by the Office of the Director civilian agency, carries a ceiling value of $5,692.44 and employs firm fixed pricing. The contract was awarded without a set-aside designation and is being performed in Rockford, Illinois.
This award represents a task order placed against an existing BPA vehicle, leveraging Thermo Electron's established relationship as a supplier of scientific instruments and related products to federal agencies. Thermo Electron Corporation maintains significant indefinite delivery vehicles across multiple federal agencies, including a $9.5 million blanket purchase agreement with the Food and Drug Administration under the GSA Multiple Award Schedule program. As a leading provider of analytical equipment and scientific instruments used in research, medical, and regulatory settings, Thermo Electron and its subsidiary Pierce Biotechnology supply critical laboratory resources to support federal research, public health initiatives, and regulatory compliance functions across agencies including the Department of Health and Human Services, Department of Defense, and the Environmental Protection Agency.
Quick answers
Who was awarded contract HHSN26300227?
HHSN26300227 was awarded to Pierce Biotechnology Inc. by Office of the Director (National Institutes of Health) on February 12, 2013.
How much is contract HHSN26300227 worth?
The government has obligated $5,692 on HHSN26300227.
Is contract HHSN26300227 an order under another contract?
Yes. HHSN26300227 is a BPA call under HHSN263199800049380B, a blanket purchase agreement.
Was contract HHSN26300227 competed?
The extent of competition for HHSN26300227 was competed under sap. The government received 3 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award